Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia (Q33393126)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

Christophe Willekens

object named as

C Willekens

6

0 references

author name string

J Rossignol

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A-S Michallet

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

L Oberic

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

M Picard

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A Garon

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

R Dulery

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

X Leleu

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

B Cazin

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

L Ysebaert

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

3 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

473-478

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Autoimmune complications of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

Disease-specific complications of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

Autoimmune complications in chronic lymphocytic leukaemia (CLL).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

21 January 2018

Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.278

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2010.278

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33393126&oldid=2195316698"